Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $138.9300 (-4.32%) ($136.0300 - $143.0000) on Fri. Oct. 27, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.01% (three month average) | RSI | 25 | Latest Price | $138.9300(-4.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(65%) DIA(58%) IBB(56%) SPLV(53%) VYM(51%) | Factors Impacting ABBV price | ABBV will decline at least -0.505% in a week (0% probabilities). VXX(-52%) VIXM(-43%) USO(-32%) GLD(-28%) TBT(-23%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.505% (StdDev 1.01%) | Hourly BBV | -1.4 () | Intraday Trend | 0.1% | | | |
|
Resistance Level | $146.93 | 5 Day Moving Average | $144.09(-3.58%) | 10 Day Moving Average | $145.65(-4.61%) | 20 Day Moving Average | $146.93(-5.44%) | To recent high | -10.2% | To recent low | 0% | Market Cap | $245.112b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |